| Identification | Back Directory | [Name]
N6-Benzoylarabinoadenosine | [CAS]
79896-97-2 | [Synonyms]
N6-Bz-2'-ara-rA
N6-Benzoylarabinoadenosine
N6-Benzoyl-2'-arabinofuranosyl-Adenosine
N6-Benzoyl-β-D-arabinofuranosyladenosine
9-(β-D-arabinofuranosyl)-N6-benzoyladenine
N6-benzoyl-9-Beta-D-arabinofuranosyladenine
9-(β-D-Arabinofuranosyl)-N6-benzoyl-D-adenine
Benzamide, N-(9-β-D-arabinofuranosyl-9H-purin-6-yl)-
N-[9-[(2R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]benzamide
N-[9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]benzamide
N-(9-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide | [Molecular Formula]
C17H17N5O5 | [MOL File]
79896-97-2.mol | [Molecular Weight]
371.35 |
| Hazard Information | Back Directory | [Uses]
N6-Benzoyl-9-β-D-arabinofuranosyladenine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1]. | [References]
[1] Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500. DOI:10.1016/j.drudis.2021.02.020 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList1701258/0_EN.htm |
|